According to Citi this month, in respect to HLS, 'Radiology performed well. Imaging revenue increased by 9% and EBIT increased by 12%.' Whilst revenue seems OK for CAJ, it is the EBIT or EBITDA which is the problem. AH must assert his authority over the now reconstituted radiology group!
According to Citi this month, in respect to HLS, 'Radiology...
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CAJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $341.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $300.3K | 811.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 135323 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 1208 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| CAJ (ASX) Chart |
